New drug shows promise in early trial for Hard-to-Treat cancers
Disease control
Terminated
This study tested a new drug called OMX-0407 in 68 people with advanced solid tumors that had not responded to previous treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was stopped early, but the results help researchers understand h…
Phase: PHASE1, PHASE2 • Sponsor: iOmx Therapeutics AG • Aim: Disease control
Last updated May 04, 2026 16:20 UTC